IN2014CN00338A - - Google Patents

Info

Publication number
IN2014CN00338A
IN2014CN00338A IN338CHN2014A IN2014CN00338A IN 2014CN00338 A IN2014CN00338 A IN 2014CN00338A IN 338CHN2014 A IN338CHN2014 A IN 338CHN2014A IN 2014CN00338 A IN2014CN00338 A IN 2014CN00338A
Authority
IN
India
Prior art keywords
capsule
intestinal wall
lumen
tract
drugs
Prior art date
Application number
Inventor
Mir Imran
Original Assignee
Rani Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47424526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014CN00338(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rani Therapeutics Llc filed Critical Rani Therapeutics Llc
Publication of IN2014CN00338A publication Critical patent/IN2014CN00338A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/073—Intestinal transmitters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Embodiments of the invention provide swallowable devices preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed tolerated and/or degraded within the GI tract.
IN338CHN2014 2011-06-29 2012-06-27 IN2014CN00338A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161571641P 2011-06-29 2011-06-29
PCT/US2012/044441 WO2013003487A1 (en) 2011-06-29 2012-06-27 Device, system and methods for the oral delivery of therapeutic compounds

Publications (1)

Publication Number Publication Date
IN2014CN00338A true IN2014CN00338A (en) 2015-04-03

Family

ID=47424526

Family Applications (1)

Application Number Title Priority Date Filing Date
IN338CHN2014 IN2014CN00338A (en) 2011-06-29 2012-06-27

Country Status (11)

Country Link
EP (3) EP3653223B1 (en)
JP (6) JP6101261B2 (en)
CN (1) CN103987422B (en)
AU (5) AU2012275417B9 (en)
CA (2) CA3159845A1 (en)
DK (2) DK2726141T3 (en)
ES (2) ES2898893T3 (en)
IN (1) IN2014CN00338A (en)
PL (2) PL2726141T3 (en)
PT (2) PT2726141T (en)
WO (1) WO2013003487A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102770151B (en) 2009-08-03 2018-07-31 因卡伯实验室有限责任公司 For stimulating what incretin in enteron aisle generated to swallow formula capsule and method
US8721620B2 (en) 2009-12-24 2014-05-13 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
JP6101261B2 (en) * 2011-06-29 2017-03-22 ラニ セラピューティクス， エルエルシー Devices, systems, and methods for oral delivery of therapeutic compounds
CA3104670A1 (en) * 2013-03-15 2014-10-02 Rani Therapeutics, Llc Device for oral delivery of therapeutic compounds
CN104605900B (en) * 2013-11-04 2017-04-12 上海交通大学医学院附属第九人民医院 Skin expander capable of simultaneously providing biological additive effect
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CN104287685B (en) * 2014-10-08 2016-03-02 南京航空航天大学 Parked and the pose adjusting device of elastic rod guide type capsule endoscope robot and method
EP3288543A4 (en) 2015-05-01 2018-11-14 Incube Labs, LLC Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
WO2016183040A1 (en) * 2015-05-08 2016-11-17 Mir Imran Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
AU2016320867B2 (en) * 2015-09-08 2023-03-30 Rani Therapeutics, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10190894B2 (en) * 2015-12-26 2019-01-29 Intel Corporation Technologies for controlling degradation of sensing circuits
CN105476593B (en) * 2015-12-30 2019-02-05 中科院合肥技术创新工程院 It is a kind of for checking the capsule endoscope of esophagel disease
US10220003B2 (en) * 2016-03-09 2019-03-05 Incube Labs, Llc Methods and articles for delivering viable cells into solid tissue
WO2018213588A1 (en) * 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Tissue anchoring articles
WO2019121686A1 (en) * 2017-12-18 2019-06-27 Egalet Ltd. Oral delivery of active drug substances
CN111526789A (en) * 2018-01-03 2020-08-11 Mi菲特皮尔医疗有限责任公司 Body-insertable apparatus with fail-safe expulsion
US10675248B2 (en) 2018-08-14 2020-06-09 Alma Therapeutics Ltd. Expandable pill
KR102047610B1 (en) * 2018-12-18 2019-11-22 이민우 Micro Needle Device with Multi Mini-Injection Part
US20220151939A1 (en) * 2019-03-14 2022-05-19 Esocap Ag Pharmaceutical dosage form for application to mucous membranes and methods for producing same
CN114650864A (en) * 2019-10-01 2022-06-21 拉尼医疗有限公司 Self-sizing device for delivery of formulations to lumen walls
CN115300774B (en) * 2022-08-27 2024-01-30 深圳市资福医疗技术有限公司 Medicament delivery device, medicament release method and medicament release capsule using same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60129057A (en) * 1983-12-14 1985-07-10 住友化学工業株式会社 Needle like solid drug administering needle
DK42093D0 (en) * 1993-04-07 1993-04-07 Bukh Meditec METHOD OF ADMINISTRATION
US6638246B1 (en) * 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
JP2006512130A (en) * 2002-12-26 2006-04-13 ギブン・イメージング・リミテツド Immobilizable in vivo sensing device
US20050058701A1 (en) * 2003-01-29 2005-03-17 Yossi Gross Active drug delivery in the gastrointestinal tract
KR20050098277A (en) * 2003-01-29 2005-10-11 이-필 파마 리미티드 Active drug delivery in the gastrointestinal tract
US20050038415A1 (en) * 2003-08-06 2005-02-17 Rohr William L. Method and apparatus for the treatment of obesity
JP4526253B2 (en) * 2003-10-01 2010-08-18 オリンパス株式会社 In-vivo observation device
DE102004026615A1 (en) * 2004-06-01 2005-12-29 Siemens Ag Apparatus and method for releasing a therapeutic agent delivered to the interior of a patient's body
EP1827387A2 (en) * 2004-12-14 2007-09-05 E-Pill Pharma Ltd. Prolonged transit time of permeability-enhancing drug eluting pill
CN101107038A (en) 2005-01-18 2008-01-16 皇家飞利浦电子股份有限公司 Electronically controlled capsule
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
DE102005032369A1 (en) 2005-07-08 2007-01-11 Siemens Ag endoscopy capsule
JP4402648B2 (en) * 2005-12-16 2010-01-20 オリンパス株式会社 Intra-subject introduction device
JP5220001B2 (en) * 2006-05-18 2013-06-26 チューリップ メディカル リミテッド Biodegradable self-expanding intragastric and non-gastric implants
US20070288033A1 (en) * 2006-06-09 2007-12-13 Allergan, Inc. Intragastric balloon retrieval mechanisms
WO2010045477A2 (en) * 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Intragastric volume-occupying device and method for fabricating same
WO2010093834A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Skin penetrating device and method for subcutaneous solid drug delivery
JP2010273936A (en) * 2009-05-29 2010-12-09 Tti Ellebeau Inc Balloon catheter
US8721620B2 (en) * 2009-12-24 2014-05-13 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
PL3461478T3 (en) 2009-12-24 2020-09-21 Rani Therapeutics, Llc Swallowable drug delivery device
JP6101261B2 (en) * 2011-06-29 2017-03-22 ラニ セラピューティクス， エルエルシー Devices, systems, and methods for oral delivery of therapeutic compounds

Also Published As

Publication number Publication date
PT2726141T (en) 2020-02-24
DK2726141T3 (en) 2020-03-02
DK3653223T3 (en) 2021-11-15
AU2020200413B2 (en) 2020-10-08
CA2840487A1 (en) 2013-01-03
JP6101261B2 (en) 2017-03-22
CA2840487C (en) 2022-09-27
JP6742383B2 (en) 2020-08-19
JP7016387B2 (en) 2022-02-04
AU2012275417B9 (en) 2017-08-31
EP3653223B1 (en) 2021-08-25
ES2765029T3 (en) 2020-06-05
JP2019055197A (en) 2019-04-11
EP3973983A1 (en) 2022-03-30
AU2012275417A1 (en) 2014-01-23
PL2726141T3 (en) 2020-06-15
AU2012275417B2 (en) 2017-04-20
PT3653223T (en) 2021-12-06
JP2017113601A (en) 2017-06-29
CN103987422A (en) 2014-08-13
AU2020294353A1 (en) 2021-02-25
CA3159845A1 (en) 2013-01-03
AU2017206226B2 (en) 2019-10-24
ES2898893T3 (en) 2022-03-09
AU2023202150A1 (en) 2023-05-04
EP2726141A1 (en) 2014-05-07
EP2726141A4 (en) 2015-05-06
JP2020171801A (en) 2020-10-22
AU2017206226A1 (en) 2017-08-03
JP2014520600A (en) 2014-08-25
AU2020294353B2 (en) 2023-01-12
AU2020200413A1 (en) 2020-02-13
JP2022044726A (en) 2022-03-17
CN103987422B (en) 2017-02-15
EP3653223A1 (en) 2020-05-20
EP2726141B1 (en) 2019-12-25
WO2013003487A1 (en) 2013-01-03
JP2024074923A (en) 2024-05-31
PL3653223T3 (en) 2021-12-20

Similar Documents

Publication Publication Date Title
IN2014CN00338A (en)
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP2726091A4 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3316872A4 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2011079302A3 (en) Swallowable drug delivery device and methods of drug delivery
EP3706720A4 (en) Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
EP3558420A4 (en) Medicament delivery device and methods for delivering drugs to infants and children
IL218071A0 (en) Novel pharmaceutical formulations to prevent the misuse of medicinal drugs
MX340822B (en) Formulations for oral delivery of adsorbents in the gut.
MX2024005949A (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
EP2571526A4 (en) Drug delivery devices for delivery of ocular therapeutic agents
PH12014502058A1 (en) Pharmaceutical composition comprising empagliflozin and antiobesity drug
HUE047187T2 (en) Device for controlling movement of capsule endoscope in human digestive tract
EP2593039A4 (en) Drug delivery medical device
EP3347050A4 (en) Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
IL221373A0 (en) System for determining treatment-related data for the administration of drugs to patients to be treated for the administration of drugs to patients to be treated taking into account important individual factors
EP2782631A4 (en) Implantable solid-liquig drug delivery apparatus, formulations, and methods of use
MX2021011047A (en) Therapeutic agent preparations and methods for drug delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
HK1208830A1 (en) Drug delivery device for the treatment of patients with respiratory diseases
EP2595633A4 (en) Methods of intravenous administration of glyburide and other drugs
BR112013014616A2 (en) transdermal therapeutic system for the administration of an active substance
MX2016001593A (en) Digestive enzyme composition suitable for enteral administration.
MX2016005232A (en) Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile.
WO2011111027A3 (en) Oral dispersible delayed release tablet formulation
WO2011146699A3 (en) Nanochanneled device and related methods